Joined Today: 0

ACAD ACADIA Pharmaceuticals,Stock Message Board

All Messages

ACAD Message Board Home | Join The ACAD Group |

#38: ACAD Stock News : ACADIA Pharmaceuticals Reports Second Quarter 2009 Financial Results
TheMachine	August 6, 2009 12:48:28 AM
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments... view message ignore post recommend post

#37: Zantrio.com Stock Picks for July 27, 2009
zantriocom	July 27, 2009 08:59:13 AM
(ACAD) - buyAcadia Pharmaceuticals surged on Friday amid speculation of imminent release of data from late-stage trial of experimental drug for psychosis brought on by Parkinson's... view message ignore post recommend post

#36: ACAD Stock News : ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis
TheMachine	May 25, 2009 05:31:30 PM
Top-Line Data Expected in the Third Quarter of 2009 ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) and Biovail Corporation (NYSE:BVF) (TSX:BVF), today announced the completion of... view message ignore post recommend post

#35: ACAD Stock News : ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
TheMachine	February 7, 2009 07:00:31 AM
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel... view message ignore post recommend post

#34: ACAD Stock News : ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta Agonists for the Treatment of Parkinson’s Disease
TheMachine	February 7, 2009 06:59:47 AM
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel... view message ignore post recommend post

#33: ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility
TheMachine	September 19, 2008 12:19:47 PM
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel... view message ignore post recommend post

#32: ACADIA Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 5, 2008
fatfingers	May 2, 2008 12:40:25 AM
ACADIA to Host Conference Call and Webcast on Monday, May 5, 2008, at 5:00 p.m. Eastern Time ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company... view message ignore post recommend post

#31: ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
fatfingers	May 2, 2008 12:39:13 AM
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel... view message ignore post recommend post

#30: ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting
Stock News Bot	April 13, 2008 03:48:34 PM
ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting ACADIA Pharmaceuticals Inc. (Nasdaq:... view message ignore post recommend post

#29: ACADIA Pharmaceuticals Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
TheMachine	February 10, 2008 06:18:05 AM
New Data Demonstrate Less Increase in Serum Glucose Levels With Pimavanserin Co-Therapy ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company ... view message ignore post recommend post

#28: ACADIA Pharmaceuticals to Present at the 26th Annual JP Morgan Healthcare Conference on January 7, 2008
Stock News Bot	January 12, 2008 07:57:04 AM
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for... view message ignore post recommend post

#27: ACADIA Pharmaceuticals Announces Completion of Enrollment of ACP-104 Phase IIb Clinical Trial Ahead of Schedule
FastFun	December 16, 2007 06:46:22 PM
Top-Line Results Expected in Q2 2008 ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical... view message ignore post recommend post

#26: ACADIA Pharmaceuticals to Webcast Its Analyst and Investor Meeting on December 14, 2007
FastFun	December 16, 2007 06:45:40 PM
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central... view message ignore post recommend post

#25: ACAD News ACADIA Pharmaceuticals Announces Proposed Public Stock Offering
Stock News Bot	April 2, 2007 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) announced today the filing of a preliminary prospectus supplement to its effective shelf registration statement... view message ignore post recommend post

#24: ACAD News ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
Stock News Bot	March 29, 2007 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#23: ACAD News ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
Stock News Bot	March 19, 2007 05:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) today announced positive top-line results from its Phase II schizophrenia co-therapy trial with ACP-103,... view message ignore post recommend post

#22: ACAD News ACADIA Pharmaceuticals to Present at Lehman Brothers 10th Annual Global Healthcare Conference
Stock News Bot	March 14, 2007 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#21: ACAD News Zacks Analyst Blog Highlights: ACADIA, BJ's Wholesale and Standard Motor Products
Stock News Bot	March 8, 2007 03:00:00 AM
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting... view message ignore post recommend post

#20: ACAD News ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2006
Stock News Bot	March 6, 2007 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#19: ACAD News ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2006 Financial Results on March 6, 2007
Stock News Bot	February 27, 2007 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#18: ACAD News ACADIA Pharmaceuticals to Present at the 25th Annual JP Morgan Healthcare Conference on January 11, 2007
Stock News Bot	January 3, 2007 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#17: ACAD News ACADIA Pharmaceuticals Adds Complementary Intellectual Property for Serotonin Platform
Stock News Bot	December 4, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#16: ACAD News ACADIA Pharmaceuticals Reports Third Quarter 2006 Financial Results
Stock News Bot	November 6, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#15: ACAD News ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Stock News Bot	November 1, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#14: ACAD News ACADIA Pharmaceuticals to Announce Third Quarter 2006 Financial Results on November 6, 2006
Stock News Bot	October 30, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#13: ACAD News ACADIA Pharmaceuticals to Support Launch of New Company Focused on Substance Abuse Therapeutics
Stock News Bot	October 23, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will provide initial seed funding to help establish Abbey Pharmaceuticals, a startup... view message ignore post recommend post

#12: ACAD News ACADIA Pharmaceuticals to Present at BIO InvestorForum 2006 on October 18, 2006
Stock News Bot	October 11, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#11: ACAD News ACADIA Pharmaceuticals Announces Accelerated Timing of ACP-103 Phase II Trial in Patients with Schizophrenia; Top-Line Results for Complete 400-Patient Study Expected in Q1 2007
Stock News Bot	September 25, 2006 04:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#10: ACAD News ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Stock News Bot	September 12, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--Sept. 12, 2006--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#9: ACAD News ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Results
Stock News Bot	August 8, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--Aug. 8, 2006--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#8: ACAD News ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Stock News Bot	August 3, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--Aug. 3, 2006--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#7: ACAD News ACADIA Pharmaceuticals to Announce Second Quarter 2006 Financial Results on August 8, 2006; ACADIA to Host Conference Call and Webcast on Tuesday, August 8, 2006, at 5:00 p.m. Eastern Time
Stock News Bot	August 2, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--Aug. 2, 2006--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#6: ACAD News ACADIA Pharmaceuticals Announces Encouraging Results from Initial Clinical Trials with ACP-104 in Patients with Schizophrenia
Stock News Bot	July 13, 2006 06:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--July 13, 2006--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of... view message ignore post recommend post

#5: ACAD Schizophrenia Programs Reviewed by NeuroInvestment
Stock News Bot	March 16, 2005 07:12:30 AM
Schizophrenia Programs Reviewed by NeuroInvestment RYE, NH - MARKET WIRE - 03/08/05 NI Research today announced the release of the March issue of NeuroInvestment, reviewing the development of... view message ignore post recommend post

#4: ACAD ACADIA Announces Management Appointments in Business Development and Research and Development
Stock News Bot	March 16, 2005 07:11:56 AM
ACADIA Announces Management Appointments in Business Development and Research and Development SAN DIEGO - PRNewswire-FirstCall - March 7 SAN DIEGO, March 7 /PRNewswire-FirstCall/ -- ACADIA... view message ignore post recommend post

#3: ACAD ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2004
Stock News Bot	March 16, 2005 07:11:15 AM
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2004 SAN DIEGO - PRNewswire-FirstCall - March 3 SAN DIEGO, March 3 /PRNewswire-FirstCall/ --... view message ignore post recommend post

#2: ACAD ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2004 Financial Results on March 3, 2005
Stock News Bot	March 16, 2005 07:10:40 AM
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2004 Financial Results on March 3, 2005 ACADIA to Host Conference Call and Webcast on Thursday, March 3, 2005 at 4:30 p.m. Eastern... view message ignore post recommend post

#1: ACAD ACADIA Pharmaceuticals Inc,Stock Trading Message Board News
Stock News Bot	March 16, 2005 07:09:53 AM
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences SAN DIEGO - PRNewswire-FirstCall - Feb. 22 SAN DIEGO, Feb. 22 /PRNewswire-FirstCall/ -- ACADIA Pharmaceuticals Inc. announced... view message ignore post recommend post

Group Home | Login if you want to post a message